Loading...

AUTL - Autolus Therapeutics plc

Top Biomed Signal for 06-25-2022
Top Biomed Stock Signal: AUTL



Stock Signal Information


Signal

Top Biomed Stock
Report Date: 06-25-2022
Symbol: AUTL - Autolus Therapeutics plc
Sector:
Industry:
Top Biomed Stock Signal: AUTL

  AUTL Technical Chart

Company Contact

Autolus Therapeutics plc (AUTL)
Scale Space Building, White City, 58 Wood Lane
LONDON, W12 7RZ
Phone: 442038296230
Website: https://www.autolus.com
CEO: Dr. Christian Martin Itin


Company Profile

Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company is developing AUTO1 and AUTO3 for B cell malignancies; AUTO2 and AUTO8 for the treatment of multiple myeloma; AUTO1/22 for the treatment of dual-targeting CAR-T; AUTO3NG for the treatment of hematological cancer; AUTO4 and AUTO5 for T cell lymphoma; AUTO6NG for the treatment of programmed T cell therapies; AUTO6 for the treatment of neuroblastoma; and AUTO7 for the treatment of prostate cancer. Autolus Therapeutics plc was founded in 2014 and is headquartered in London, the United Kingdom.